These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 20626408

  • 1. Structure-based in silico design of a high-affinity dipeptide inhibitor for novel protein drug target Shikimate kinase of Mycobacterium tuberculosis.
    Kumar M, Verma S, Sharma S, Srinivasan A, Singh TP, Kaur P.
    Chem Biol Drug Des; 2010 Sep 01; 76(3):277-84. PubMed ID: 20626408
    [Abstract] [Full Text] [Related]

  • 2. Structure of shikimate kinase from Mycobacterium tuberculosis reveals the binding of shikimic acid.
    Pereira JH, de Oliveira JS, Canduri F, Dias MV, Palma MS, Basso LA, Santos DS, de Azevedo WF.
    Acta Crystallogr D Biol Crystallogr; 2004 Dec 01; 60(Pt 12 Pt 2):2310-9. PubMed ID: 15583379
    [Abstract] [Full Text] [Related]

  • 3. Structure-based design of a potent and selective small peptide inhibitor of Mycobacterium tuberculosis 6-hydroxymethyl-7, 8-dihydropteroate synthase: a computer modelling approach.
    Rao GS, Kumar M.
    Chem Biol Drug Des; 2008 Jun 01; 71(6):540-5. PubMed ID: 18482337
    [Abstract] [Full Text] [Related]

  • 4. Molecular model of shikimate kinase from Mycobacterium tuberculosis.
    Filgueira de Azevedo W, Canduri F, Simões de Oliveira J, Basso LA, Palma MS, Pereira JH, Santos DS.
    Biochem Biophys Res Commun; 2002 Jul 05; 295(1):142-8. PubMed ID: 12083781
    [Abstract] [Full Text] [Related]

  • 5. Crystal structure of shikimate kinase from Mycobacterium tuberculosis reveals the dynamic role of the LID domain in catalysis.
    Gu Y, Reshetnikova L, Li Y, Wu Y, Yan H, Singh S, Ji X.
    J Mol Biol; 2002 Jun 07; 319(3):779-89. PubMed ID: 12054870
    [Abstract] [Full Text] [Related]

  • 6. Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening.
    Segura-Cabrera A, Rodríguez-Pérez MA.
    Bioorg Med Chem Lett; 2008 Jun 01; 18(11):3152-7. PubMed ID: 18486472
    [Abstract] [Full Text] [Related]

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 01; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 8. Interaction of shikimic acid with shikimate kinase.
    Pereira JH, de Oliveira JS, Canduri F, Dias MV, Palma MS, Basso LA, de Azevedo WF, Santos DS.
    Biochem Biophys Res Commun; 2004 Dec 03; 325(1):10-7. PubMed ID: 15522194
    [Abstract] [Full Text] [Related]

  • 9. Identification of shikimate kinase inhibitors among anti-Mycobacterium tuberculosis compounds by LC-MS.
    Simithy J, Reeve N, Hobrath JV, Reynolds RC, Calderón AI.
    Tuberculosis (Edinb); 2014 Mar 03; 94(2):152-8. PubMed ID: 24429106
    [Abstract] [Full Text] [Related]

  • 10. Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis.
    Rajput VS, Mehra R, Kumar S, Nargotra A, Singh PP, Khan IA.
    Appl Microbiol Biotechnol; 2016 Jun 03; 100(12):5415-26. PubMed ID: 26887318
    [Abstract] [Full Text] [Related]

  • 11. A novel inhibitor of indole-3-glycerol phosphate synthase with activity against multidrug-resistant Mycobacterium tuberculosis.
    Shen H, Wang F, Zhang Y, Huang Q, Xu S, Hu H, Yue J, Wang H.
    FEBS J; 2009 Jan 03; 276(1):144-54. PubMed ID: 19032598
    [Abstract] [Full Text] [Related]

  • 12. Benzothiazole Derivative as a Novel Mycobacterium tuberculosis Shikimate Kinase Inhibitor: Identification and Elucidation of Its Allosteric Mode of Inhibition.
    Mehra R, Rajput VS, Gupta M, Chib R, Kumar A, Wazir P, Khan IA, Nargotra A.
    J Chem Inf Model; 2016 May 23; 56(5):930-40. PubMed ID: 27149193
    [Abstract] [Full Text] [Related]

  • 13. Structural studies of shikimate 5-dehydrogenase from Mycobacterium tuberculosis.
    Arcuri HA, Borges JC, Fonseca IO, Pereira JH, Neto JR, Basso LA, Santos DS, de Azevedo WF.
    Proteins; 2008 Aug 23; 72(2):720-30. PubMed ID: 18260104
    [Abstract] [Full Text] [Related]

  • 14. Mycobacterium tuberculosis shikimate kinase inhibitors: design and simulation studies of the catalytic turnover.
    Blanco B, Prado V, Lence E, Otero JM, Garcia-Doval C, van Raaij MJ, Llamas-Saiz AL, Lamb H, Hawkins AR, González-Bello C.
    J Am Chem Soc; 2013 Aug 21; 135(33):12366-76. PubMed ID: 23889343
    [Abstract] [Full Text] [Related]

  • 15. Structure-based design of a novel class of potent inhibitors of InhA, the enoyl acyl carrier protein reductase from Mycobacterium tuberculosis: a computer modelling approach.
    Subba Rao G, Vijayakrishnan R, Kumar M.
    Chem Biol Drug Des; 2008 Nov 21; 72(5):444-9. PubMed ID: 19012578
    [Abstract] [Full Text] [Related]

  • 16. Shikimate kinase (EC 2.7.1.71) from Mycobacterium tuberculosis: kinetics and structural dynamics of a potential molecular target for drug development.
    Saidemberg DM, Passarelli AW, Rodrigues AV, Basso LA, Santos DS, Palma MS.
    Curr Med Chem; 2011 Nov 21; 18(9):1299-310. PubMed ID: 21366533
    [Abstract] [Full Text] [Related]

  • 17. Mechanism of phosphoryl transfer catalyzed by shikimate kinase from Mycobacterium tuberculosis.
    Hartmann MD, Bourenkov GP, Oberschall A, Strizhov N, Bartunik HD.
    J Mol Biol; 2006 Dec 01; 364(3):411-23. PubMed ID: 17020768
    [Abstract] [Full Text] [Related]

  • 18. Cloning and overexpression in soluble form of functional shikimate kinase and 5-enolpyruvylshikimate 3-phosphate synthase enzymes from Mycobacterium tuberculosis.
    Oliveira JS, Pinto CA, Basso LA, Santos DS.
    Protein Expr Purif; 2001 Aug 01; 22(3):430-5. PubMed ID: 11483005
    [Abstract] [Full Text] [Related]

  • 19. Structure-aided design of inhibitors of Mycobacterium tuberculosis thymidylate kinase.
    Van Calenbergh S.
    Verh K Acad Geneeskd Belg; 2006 Aug 01; 68(4):223-48. PubMed ID: 17214439
    [Abstract] [Full Text] [Related]

  • 20. Crystallographic studies of shikimate binding and induced conformational changes in Mycobacterium tuberculosis shikimate kinase.
    Dhaliwal B, Nichols CE, Ren J, Lockyer M, Charles I, Hawkins AR, Stammers DK.
    FEBS Lett; 2004 Sep 10; 574(1-3):49-54. PubMed ID: 15358538
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.